UTHR logo

United Therapeutics (UTHR) Free cash flow

annual FCF:

$1.08B+$333.00M(+44.54%)
December 31, 2024

Summary

  • As of today (May 29, 2025), UTHR annual free cash flow is $1.08 billion, with the most recent change of +$333.00 million (+44.54%) on December 31, 2024.
  • During the last 3 years, UTHR annual FCF has risen by +$603.20 million (+126.35%).
  • UTHR annual FCF is now at all-time high.

Performance

UTHR Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

quarterly FCF:

$386.30M+$131.80M(+51.79%)
March 31, 2025

Summary

  • As of today (May 29, 2025), UTHR quarterly free cash flow is $386.30 million, with the most recent change of +$131.80 million (+51.79%) on March 31, 2025.
  • Over the past year, UTHR quarterly FCF has increased by +$48.00 million (+14.19%).
  • UTHR quarterly FCF is now at all-time high.

Performance

UTHR quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

TTM FCF:

$1.13B+$48.00M(+4.44%)
March 31, 2025

Summary

  • As of today (May 29, 2025), UTHR TTM free cash flow is $1.13 billion, with the most recent change of +$48.00 million (+4.44%) on March 31, 2025.
  • Over the past year, UTHR TTM FCF has increased by +$376.20 million (+50.00%).
  • UTHR TTM FCF is now at all-time high.

Performance

UTHR TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

UTHR Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+44.5%+14.2%+50.0%
3 y3 years+126.3%+40.4%+67.6%
5 y5 years+472.2%+91.6%+100.2%

UTHR Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+126.3%at high+527.1%at high+73.2%
5 y5-yearat high+472.2%at high+527.1%at high+136.4%
alltimeall timeat high+472.2%at high+159.2%at high+437.4%

UTHR Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$386.30M(+51.8%)
$1.13B(+4.4%)
Dec 2024
$1.08B(+44.5%)
$254.50M(-15.4%)
$1.08B(+20.3%)
Sep 2024
-
$300.70M(+60.7%)
$898.10M(+2.3%)
Jun 2024
-
$187.10M(-44.7%)
$877.90M(+16.7%)
Mar 2024
-
$338.30M(+369.9%)
$752.40M(+0.6%)
Dec 2023
$747.60M(+12.6%)
$72.00M(-74.3%)
$747.60M(-2.2%)
Sep 2023
-
$280.50M(+355.4%)
$764.30M(+13.5%)
Jun 2023
-
$61.60M(-81.5%)
$673.60M(-6.7%)
Mar 2023
-
$333.50M(+276.0%)
$722.00M(+8.8%)
Dec 2022
$663.70M(+39.0%)
$88.70M(-53.3%)
$663.70M(-2.3%)
Sep 2022
-
$189.80M(+72.5%)
$679.00M(+4.2%)
Jun 2022
-
$110.00M(-60.0%)
$651.50M(-3.3%)
Mar 2022
-
$275.20M(+164.6%)
$673.40M(+41.1%)
Dec 2021
$477.40M(-31.4%)
$104.00M(-35.9%)
$477.40M(-2.0%)
Sep 2021
-
$162.30M(+23.0%)
$487.30M(-13.0%)
Jun 2021
-
$131.90M(+66.5%)
$560.10M(-2.4%)
Mar 2021
-
$79.20M(-30.5%)
$574.00M(-17.6%)
Dec 2020
$696.40M(-339.9%)
$113.90M(-51.6%)
$696.40M(+5.5%)
Sep 2020
-
$235.10M(+61.2%)
$660.30M(+10.6%)
Jun 2020
-
$145.80M(-27.7%)
$597.00M(+5.9%)
Mar 2020
-
$201.60M(+159.1%)
$563.80M(-294.2%)
Dec 2019
-$290.30M(-148.9%)
$77.80M(-54.7%)
-$290.30M(-13.2%)
Sep 2019
-
$171.80M(+52.6%)
-$334.50M(+7.8%)
Jun 2019
-
$112.60M(-117.3%)
-$310.30M(+4.6%)
Mar 2019
-
-$652.50M(-2042.0%)
-$296.60M(-149.9%)
Dec 2018
$594.00M(+53.1%)
$33.60M(-82.9%)
$594.00M(+32.9%)
Sep 2018
-
$196.00M(+55.2%)
$446.80M(-8.3%)
Jun 2018
-
$126.30M(-47.0%)
$487.30M(+18.6%)
Mar 2018
-
$238.10M(-309.6%)
$410.80M(+5.9%)
Dec 2017
$387.90M(-35.9%)
-$113.60M(-148.0%)
$387.90M(-40.8%)
Sep 2017
-
$236.50M(+374.9%)
$655.40M(+2.6%)
Jun 2017
-
$49.80M(-76.9%)
$638.50M(-9.3%)
Mar 2017
-
$215.20M(+39.8%)
$704.00M(+16.2%)
Dec 2016
$605.60M(+81.9%)
$153.90M(-29.9%)
$605.60M(+35.9%)
Sep 2016
-
$219.60M(+90.5%)
$445.70M(+5.4%)
Jun 2016
-
$115.30M(-1.3%)
$422.80M(+22.7%)
Mar 2016
-
$116.80M(-2046.7%)
$344.70M(+3.5%)
Dec 2015
$333.00M(+8.2%)
-$6.00M(-103.1%)
$333.00M(-22.1%)
Sep 2015
-
$196.70M(+428.8%)
$427.40M(+0.4%)
Jun 2015
-
$37.20M(-64.6%)
$425.60M(+32.6%)
Mar 2015
-
$105.10M(+18.9%)
$321.08M(+4.3%)
Dec 2014
$307.90M(-21.7%)
$88.40M(-54.6%)
$307.90M(-0.8%)
Sep 2014
-
$194.89M(-389.5%)
$310.50M(+26.5%)
Jun 2014
-
-$67.32M(-173.2%)
$245.50M(-37.3%)
Mar 2014
-
$91.92M(+1.0%)
$391.82M(-0.4%)
Dec 2013
$393.36M(+85.8%)
$91.01M(-29.9%)
$393.36M(+1.8%)
Sep 2013
-
$129.88M(+64.4%)
$386.30M(+12.6%)
Jun 2013
-
$79.01M(-15.5%)
$343.14M(+11.5%)
Mar 2013
-
$93.45M(+11.3%)
$307.88M(+45.4%)
Dec 2012
$211.72M(-1.2%)
$83.95M(-3.2%)
$211.72M(+17.5%)
Sep 2012
-
$86.72M(+98.2%)
$180.15M(+15.3%)
Jun 2012
-
$43.75M(-1722.1%)
$156.26M(-5.0%)
Mar 2012
-
-$2.70M(-105.1%)
$164.50M(-23.2%)
DateAnnualQuarterlyTTM
Dec 2011
$214.22M(+11.1%)
$52.38M(-16.6%)
$214.22M(+9.5%)
Sep 2011
-
$62.84M(+20.9%)
$195.65M(-15.5%)
Jun 2011
-
$51.99M(+10.6%)
$231.56M(+9.2%)
Mar 2011
-
$47.02M(+39.1%)
$212.05M(+9.9%)
Dec 2010
$192.89M(+4362.0%)
$33.81M(-65.8%)
$192.89M(+17.7%)
Sep 2010
-
$98.75M(+204.0%)
$163.90M(+187.1%)
Jun 2010
-
$32.48M(+16.6%)
$57.08M(+15.5%)
Mar 2010
-
$27.86M(+478.5%)
$49.41M(+1043.0%)
Dec 2009
$4.32M(-102.5%)
$4.82M(-159.7%)
$4.32M(-102.6%)
Sep 2009
-
-$8.07M(-132.5%)
-$163.99M(-11.6%)
Jun 2009
-
$24.81M(-244.0%)
-$185.53M(-12.8%)
Mar 2009
-
-$17.23M(-89.5%)
-$212.68M(+22.5%)
Dec 2008
-$173.61M(-1787.3%)
-$163.50M(+452.1%)
-$173.61M(+330.6%)
Sep 2008
-
-$29.61M(+1168.3%)
-$40.32M(-533.7%)
Jun 2008
-
-$2.33M(-110.7%)
$9.30M(-64.6%)
Mar 2008
-
$21.84M(-172.3%)
$26.26M(+155.3%)
Dec 2007
$10.29M(-69.5%)
-$30.21M(-251.0%)
$10.29M(-67.2%)
Sep 2007
-
$20.00M(+36.7%)
$31.41M(+21.5%)
Jun 2007
-
$14.63M(+149.7%)
$25.85M(+6.6%)
Mar 2007
-
$5.86M(-164.5%)
$24.24M(-28.2%)
Dec 2006
$33.75M(-8.9%)
-$9.09M(-162.9%)
$33.75M(-30.3%)
Sep 2006
-
$14.44M(+10.9%)
$48.46M(-0.5%)
Jun 2006
-
$13.02M(-15.3%)
$48.69M(+2.0%)
Mar 2006
-
$15.38M(+173.7%)
$47.72M(+28.8%)
Dec 2005
$37.05M(+138.1%)
$5.62M(-61.7%)
$37.05M(+9.6%)
Sep 2005
-
$14.68M(+21.8%)
$33.81M(+20.1%)
Jun 2005
-
$12.05M(+155.8%)
$28.16M(+38.0%)
Mar 2005
-
$4.71M(+98.3%)
$20.40M(+31.1%)
Dec 2004
$15.56M(-200.0%)
$2.38M(-73.7%)
$15.56M(-808.9%)
Sep 2004
-
$9.03M(+110.5%)
-$2.19M(-70.4%)
Jun 2004
-
$4.29M(-3502.4%)
-$7.42M(-47.8%)
Mar 2004
-
-$126.00K(-99.2%)
-$14.20M(-8.8%)
Dec 2003
-$15.57M(-39.8%)
-$15.38M(-504.7%)
-$15.57M(+1727.0%)
Sep 2003
-
$3.80M(-252.3%)
-$852.00K(-93.6%)
Jun 2003
-
-$2.50M(+67.3%)
-$13.36M(-27.2%)
Mar 2003
-
-$1.49M(+123.5%)
-$18.34M(-29.0%)
Dec 2002
-$25.84M(-34.7%)
-$667.00K(-92.3%)
-$25.84M(-21.2%)
Sep 2002
-
-$8.70M(+16.4%)
-$32.80M(-9.3%)
Jun 2002
-
-$7.48M(-16.9%)
-$36.17M(-9.1%)
Mar 2002
-
-$8.99M(+17.9%)
-$39.79M(+0.5%)
Dec 2001
-$39.59M(+24.7%)
-$7.63M(-36.8%)
-$39.59M(-6.3%)
Sep 2001
-
-$12.08M(+8.9%)
-$42.26M(+19.5%)
Jun 2001
-
-$11.09M(+26.3%)
-$35.37M(+6.3%)
Mar 2001
-
-$8.79M(-14.7%)
-$33.28M(+4.8%)
Dec 2000
-$31.75M(+22.1%)
-$10.30M(+98.6%)
-$31.75M(+7.4%)
Sep 2000
-
-$5.19M(-42.4%)
-$29.56M(-6.1%)
Jun 2000
-
-$9.01M(+24.1%)
-$31.47M(+4.3%)
Mar 2000
-
-$7.26M(-10.4%)
-$30.16M(+16.0%)
Dec 1999
-$26.00M(+145.3%)
-$8.10M(+14.1%)
-$26.00M(+45.3%)
Sep 1999
-
-$7.10M(-7.8%)
-$17.90M(+65.7%)
Jun 1999
-
-$7.70M(+148.4%)
-$10.80M(+248.4%)
Mar 1999
-
-$3.10M
-$3.10M
Dec 1998
-$10.60M
-
-

FAQ

  • What is United Therapeutics annual free cash flow?
  • What is the all time high annual FCF for United Therapeutics?
  • What is United Therapeutics annual FCF year-on-year change?
  • What is United Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for United Therapeutics?
  • What is United Therapeutics quarterly FCF year-on-year change?
  • What is United Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for United Therapeutics?
  • What is United Therapeutics TTM FCF year-on-year change?

What is United Therapeutics annual free cash flow?

The current annual FCF of UTHR is $1.08B

What is the all time high annual FCF for United Therapeutics?

United Therapeutics all-time high annual free cash flow is $1.08B

What is United Therapeutics annual FCF year-on-year change?

Over the past year, UTHR annual free cash flow has changed by +$333.00M (+44.54%)

What is United Therapeutics quarterly free cash flow?

The current quarterly FCF of UTHR is $386.30M

What is the all time high quarterly FCF for United Therapeutics?

United Therapeutics all-time high quarterly free cash flow is $386.30M

What is United Therapeutics quarterly FCF year-on-year change?

Over the past year, UTHR quarterly free cash flow has changed by +$48.00M (+14.19%)

What is United Therapeutics TTM free cash flow?

The current TTM FCF of UTHR is $1.13B

What is the all time high TTM FCF for United Therapeutics?

United Therapeutics all-time high TTM free cash flow is $1.13B

What is United Therapeutics TTM FCF year-on-year change?

Over the past year, UTHR TTM free cash flow has changed by +$376.20M (+50.00%)
On this page